Enzo Biochem Inc
(ENZB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
| 10-2012 | 07-2012 | 04-2012 | 01-2012 | 10-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,691 | -39,269 | -12,126 | -8,715 | -4,494 |
| Depreciation Amortization | 1,149 | 4,477 | 3,286 | 2,259 | 1,222 |
| Income taxes - deferred | -197 | -1,762 | -89 | -62 | -34 |
| Accounts receivable | -1,410 | -4,210 | -2,398 | -750 | -724 |
| Accounts payable and accrued liabilities | -1,125 | 1,031 | -713 | -130 | -1,341 |
| Other Working Capital | -192 | 81 | -1,858 | -263 | -438 |
| Other Operating Activity | 3,989 | 33,680 | 7,502 | 4,108 | 3,507 |
| Operating Cash Flow | $-1,477 | $-5,972 | $-6,396 | $-3,553 | $-2,302 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 10,000 | N/A | N/A | N/A |
| PPE Investments | -291 | -1,364 | -979 | -544 | -252 |
| Other Investing Activity | -44 | -1,175 | -1,202 | -1,121 | -106 |
| Investing Cash Flow | $-335 | $7,461 | $-2,181 | $-1,665 | $-358 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -28 | -154 | -105 | -68 | -33 |
| Financing Cash Flow | $-28 | $-154 | $-105 | $-68 | $-33 |
| Exchange Rate Effect | 165 | -420 | -232 | -286 | -91 |
| Beginning Cash Position | 15,076 | 14,161 | 14,161 | 14,161 | 14,161 |
| End Cash Position | 13,401 | 15,076 | 5,247 | 8,589 | 11,377 |
| Net Cash Flow | $-1,675 | $915 | $-8,914 | $-5,572 | $-2,784 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,477 | -5,972 | -6,396 | -3,553 | -2,302 |
| Capital Expenditure | -291 | -1,364 | -979 | -544 | -252 |
| Free Cash Flow | -1,768 | -7,336 | -7,375 | -4,097 | -2,554 |